Researchers in Denmark conducted a prospective single-centre study including 160 patients with newly diagnosed high-risk prostate cancer between 2021 and 2024. All the participants first underwent an ...

Surgery patients staged with PSMA-PET appear to have a lower risk of early BCR than those staged with conventional imaging. Early oncologic outcomes after radical prostatectomy (RP) for very high risk ...

Alessa Therapeutics ("Alessa"), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology ...

Prostate cancer can be difficult to detect in its beginning stages — here's what to look out for Prostate cancer is one of the most common types of cancer in males. It starts in the prostate, a small ...

Early detection of prostate cancer remains a major clinical challenge due to the lack of reliable biomarkers, despite the disease being highly treatable when caught in its early stages. Now, ...

Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...

Prostate cancer is the second leading cause of cancer-related death in men, behind heart disease. According to the American Cancer Society, about one in eight men will be diagnosed with prostate ...

Prostate cancer is one of the most common cancers among men in the U.S. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime, according to the American Cancer Society. But experts ...

Patrick Shannon of Kenhorst was relishing a new phase of life — retirement from his careers in construction and security — when his primary care doctor called with unexpected news. Shannon’s recent ...